v3.26.3
ASSET ACQUISITION (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
May 18, 2026
Mar. 25, 2026
Sep. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Asset Acquisition [Line Items]          
Amortization expense       $ 167 $ 0
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member] | Share Purchase Agreement [Member]          
Asset Acquisition [Line Items]          
Number of shares issued   1,250,363      
Warrants to purchase ordinary shares   1,006,113      
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member] | Share Purchase Agreement [Member] | Warrant [Member]          
Asset Acquisition [Line Items]          
Number of shares issued   1,296,296      
Per share price of shares issued   $ 5.4      
Asset Acquisition Of Oratech Pharmaceuticals Ltd [Member] | Share Purchase Agreement [Member]          
Asset Acquisition [Line Items]          
Consideration transferred   $ 12,422      
Cash payment   6,500      
Prepaid clinical trial services asset   975      
Consideration transferred of intellectual property   $ 5,900      
Asset Acquisition Of Skelable Acquisition [Member]          
Asset Acquisition [Line Items]          
Consideration transferred $ 442        
Cash payment 20        
Contingent consideration upon achievement of milestone $ 250        
Estimated Useful Life (Years)     5 years 5 years  
Amortization expense     $ 23 $ 33  
Asset Acquisition Of Skelable Acquisition [Member] | Ordinary Share [Member]          
Asset Acquisition [Line Items]          
Number of stocks issued for acquisitions 34,328